Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Histotripsy Plus Chemotherapy for Advanced Colorectal Liver Metastasis
NCT07044362Recruiting
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in colorectal cancer (CRC), sponsored by Case Comprehensive Cancer Center. Primary endpoint: Radiologic tumor viability at 90 days. Started Nov 2025; status: recruiting.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07044362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07044362.